中国细菌耐药性现状(英文版).ppt
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 中国 细菌 耐药性 现状 英文
- 资源描述:
-
单击此处编辑母版标题样式,*,单击此处编辑母版文本样式,第二级,第三级,第四级,第五级,Bacterial Resistance in China,Minggui Wang,M.D.,Institute of Antibiotics,Huashan Hospital,Fudan University,Outline,Antimicrobial Resistance and Its Mechanisms,Gram-positive cocci,Streptococcus pneumoniae,Staphylococcus spp.,Gram-negative bacilli,Enterobacteriaceae,Escherichia coli,Klebsiella spp.,Enterobacter spp,.,et al.,Non-fermenting gram-negative bacilli,(non-fermenters),Antimicrobial Resistance,in,Streptococcus pneumoniae,History of studies on antimicrobial resistance on,Streptococcus pneumoniae,19671970 1978 1980 1991 2001,Spread around the world,First case of,PRSP,First case of,MDR,Mechanism of,PRSP,Regional problem,Global problem,-lactams(penicillin),Macrolides,Fluoroquinolones,Penicillin resistance in,S.pneumoniae,in China in early 2000,Year,Region,Population,Source,No.of Strains,PNSSP,(%),PISP,(%),PRSP,(%),2001,Shanghai,Children,Clinical,100,55,49,6,01-02,Beijing,Shenyang,Clinical,192,43,32,11,00-02,3 centers,Children,Clinical,887,40,34,6,00-01,4 centers,Children,Clinical,624,41,37,4,PNSSP,penicillin non-susceptible,S.pneumoniae,;PISP,penicillin intermediate,S.pneumoniae,;,PRSP,penicillin resistant,S.pneumoniae,Penicillin resistance in,S.pneumoniae,has been increasing markedly since 2000,Increasing trends of,Penicillin resistance in,S.pneumoniae,in China,Shanghai,100 strains each year,Beijing,More than 100 strains each year,Clinical strains isolated from Childrens Hospital,Reasons causing the rapid increasing of penicillin resistance,The increasing consumption of oral penicillins such as amoxicillin,The spead of,resistant,colonines,Resistance of,S.pneumoniae,to macrolides,70%-90%,of,S.pneumoniae,clinical isolates were resistant to erythromycin,Antimicrobial resistance of,S.pneumoniae,isolated from children in Beijing,Shanghai,Guangzhou and Xian(20002001),Mechanisms of resistance to macrolides,(Wang M.Diagn Microbial Infect Dis 2001;39:187),Target modification,Phenotype cMLS,90%,(159/176),Phenotype iMLS,6%,(10/176),Active efflux,Phenotype M,4%,(7/176),Trends of methicillin resistant,Staphylococcus,spp.(MRS)in China,5%-24%,35%-60%,50%-70%,Mechanism of MRSA,MRSA contain novel,PBP2a,substitutes for native PBPs;low affinity for all,-lactams,PBP2a is encoded by,mecA,gene;expression controlled by mecI,mecR1 and other factors,Antimicrobial Resistance,in,Enterobacteriaceae,Antimicrobial resistance rates of,E.coli,isolated in China in 2005(n=3758),Wang F.Chin J Infect Chemother 2006;6:289,Antimicrobial resistance rates of,K.pneumoniae,in China in 2005(n=2234),Wang F.Chin J Infect Chemother 2006;6:289,Extended-spectrum,-lactamases(ESBLs),in Enterobacteriaceae in China,ESBL-producing strains,Hospital-acquired infections,1,:,E.coli,11-47%,K.pneumoniae,14-51%,Community-acquired infections,2,:,E.coli,16%,K.pneumoniae,17%,The main genotype of ESBLs is,CTX-M,1,typically provides resistance to ceftaxime but often not to ceftazidime or aztreonam,3,1,Xiong Z.Diagn Microbiol Infect Dis 2002;44:195,2,Ling TK.AAC 2006;50:374,3,Jacoby GA.Chin J Infect Chemother 2006;6:361,Quinolone resistance rates in clinical isolates of,E.coli,in Shanghai,Plasmid-mediated quinolone resistance:,qnr,determinats,R,S,R,R,S,R,Conjugation,Transformation,R,qnr,qnrA,:Lancet,1998,the U.S.,qnrB,:AAC,2006,the U.S.,qnrS,:AAC,2005,Japan,qnrC,:7,th,NCCM,2007,China,Plasmid-mediated quinolone resistance,qnr,family:,qnrA,qnrB,qnrS,qnrC,Protection of quinolone targets,aac(6)-Ib-cr,(2006),aminoglycoside acetyltransferase,qepA,(2007),q,uinolone,e,fflux,p,ump,Summary,Antimicrobial resistance in gram-negative bacilli,ESBLs-producing strains of,E.coli,and,K.pneumoniae,are common,and spreading from hospital to community,Quinolone resistance rates in,E.coli,are especially high,New mechanisms of plasmid-mediated quinolone resistance emerged,Importance of non-fermenters,Non-fermenting gram-negative bacilli(non-fermenters)include:,Pseudomonas aeruginosa,Acinetobacter,spp.,Stenotrophomonas maltophilia,Alcaligenes,spp.,Burkholderia,spp,Flavobacterium,(,Chryseobaterium,)spp.,et al,Non-fermenters are highly resistant to commonly used antimicrobials,The infections of non-fermenters are difficult to treat with high mortality,Percentage of non-fermenters in gram-negative bacilli in Shanghai hospitals,(,Wang F,et al.Int J Antimicrob Agents 2003;22:444),1460,1632,1215,1171,1369,1661,2028,3028,3275,3005,5242,5656,4818,5819,5665,Year,No of strains,Resistance pro 6123 strains of non-fermenters against 8 antimicrobials in CHINET in 2005,(Wang F.Chin J Infect Chemother 2006;6:289),Antimicrobial agents,Resistance rate(%),Susceptibility rate(%),Ceftazidime,41,52,Cefepime,45,46,Piperacillin-tazobactam,44,49,Cefoperazone-sulbactam,23,52,Imipenem,43,54,Meropenem,43,55,Ciprofloxacin,41,48,Amikacin,46,48,Trends in antimicrobial resistance rates among strains of,P.aeruginosa,isolated from Shanghai hospitals(%),Antimicrobial agents,1993*,(232),2000,(1790),2001,(2302),2002,(2457),2003,(2123),2004,(2287),2005,(2520),Piperacillin,24,31,33,30,33,33,34,Ceftazidime,8,17,21,20,20,24,19,Cefoperazone,20,26,30,29,30,31,28,Cefepime,-,-,17,16,17,17,15,Piperacillin-tazobactam,-,-,29,27,26,26,24,Ticarcillin-clavulanic acid,-,37,47,47,37,43,38,Cefoperazone-sulbactam,-,15,15,14,15,15,13,Imipenem,6,17,24,26,25,21,21,Meropenem,-,14,21,-,17,24,23,Gentamicin,36,33,34,35,38,33,32,Amikacin,8,20,23,21,20,20,17,Ciprofloxacin,13,28,27,19,25,21,24,*Testing year,number of isolates in the parentheses,Mechanisms of resistance to imipenem in,P.aeruginosa,Producing of,-lactamases:,carbapenemases,IMP,VIM,OXA,KPC,GIM,SPM families,ESBLs,AmpC,Decreased permeability:lost of porin D2,Active efflux,X,Efflux,Inactivation,Decreased,permeability,Trends in antimicrobial resistance rates among strains of,Acinetobacter spp.,isolated from Shanghai hospitals(%),Antimicrobial agents,1999*,(1199),2000,(1365),2001,(1851),2002,(2056),2003,(1686),2004,(2191),2005,(2418),Piperacillin,41,51,44,42,49,52,57,Ceftazidime,40,46,30,38,43,45,50,Cefoperazone,64,-,57,59,65,79,-,Cefepime,-,33,29,29,35,37,43,Piperacillin-tazobactam,19,-,20,27,30,32,37,Ampicillin-sulbactam,11,16,19,21,19,22,30,Cefoperazone-sulbactam,-,-,5,6,8,9,14,Imipenem,4,3,3,2,4,4,10,Meropenem,-,4,3,-,5,6,11,Gentamicin,42,49,42,41,46,50,54,Amikacin,31,33,31,31,33,36,41,Ciprofloxacin,37,45,37,38,42,46,50,*Testing year,number of isolates in the parentheses,Antimicrobial resistance rates among ICU strains of,Acinetobacter,spp.in China between 2003 and 2004(%),(,Wang H,et al.Chin J Lab Med 2005;28:1295),Antimicrobial agents,2003,2004,Ceftazidime,47,50,Cefepime,51,52,Piperacillin-tazobactam,27,30,Cefoperazone-sulbactam,11,13,Imipenem,4.5,18,Meropenem,4.5,17,Amikacin,41,52,Ciprofloxacin,53,59,Outbreak of carbapenem-resistant,A.baumannii,in Beijing and Guangzhou,(Wang H,et al.Chin J Lab Med 2005;28:636),MDR-AB,resistant to 3 of the following 5 drugs:Pip/TAZ,CAZ,Sul/CFP,Gen,Cip,Imi,5%in 1995 67%in 2002 in BJ,20%in 1998 57%in 2002 in GZ,90%(35/39)strains produced,OXA-23,carbapenemase,PFGE results indicated resistance colonies spread in each of 4 hospitals,mainly in patients with VAP and surgical infections,Lane 1-3,5,8,11-16 PFGE type A,indicating same colony,Outbreak of COS-AB in Shanghai,(Yang L,et al.Natl Med J China 2006;86:592),Outbreak of COS-AB(colistin-only-sensitive,A.baumannii,)in some hospitals,PFGE type B strains caused outbreak of COS-AB in burn ward in a Shanghai hospital,PFGE type A strains of COS-AB spread in surgical wards,Lane 5-10,13-14,PFGE type A,Lane 3-4,12,PFGE type B,Trends in antimicrobial resistance rates among strains of,S.maltophilia,isolated from Shanghai hospitals(%),Antimicrobial agents,1999*,(271),2000,(323),2001,(581),2002,(573),2003,(448),2004,(583),2005,(751),Piperacillin,69,77,59,65,68,74,73,Ceftazidime,53,37,33,40,38,38,37,Cefoperazone,38,27,22,33,33,44,42,Cefepime,-,-,36,49,38,46,48,Piperacillin-tazobactam,-,-,40,51,56,57,53,Ticarcillin-clavulanic acid,36,23,13,33,26,30,35,Cefoperazone-sulbactam,-,14,9,18,17,18,22,Imipenem,91,96,96,98,98,98,97,Meropenem,-,89,65,50,79,85,83,Gentamicin,70,75,74,78,76,79,76,Amikacin,68,75,75,78,71,75,68,Ciprofloxacin,13,18,17,12,13,19,22,Trimethoprim-sulfamethoxazole,31,24,15,13,31,21,20,Summary,Antimicrobial resistance in non-fermenters,The isolation of non-fermenters has been increasing in recent years,The resistance rates of non-fermenters have been increasing,More than 20%strains of,P.aeruginosa,are resistant to imipenem,There were reports of outbreak of carbapenem-resistant,A.baumannii,Conclusions,Antimicrobial resistance becomes a big problem in the field of Infectious Diseases in China,Rational use of antimicrobials is the most important way to decrease or hinder antimicrobial resistance,Huashan Hospital,Bird View,THANK YOU,展开阅读全文

咨信网声明:本文档由用户上传并分享,仅供学习交流、研究之用,未经授权,严禁复制、发行、汇编、翻译或网络传播等,侵权必究。
咨信网小贴示:
1、浏览或下载可查看了解,请点击【咨信网告知】。
2、下载文件中如有侵权或不适当内容,将立即纠正。
3、如果因为网速或其他原因下载失败请重新下载,重复下载[60天内]不扣币。
4、开具发票登录电脑端申请,请点击【索取发票】。
咨信网客服组:【微信客服】
1、浏览或下载可查看了解,请点击【咨信网告知】。
2、下载文件中如有侵权或不适当内容,将立即纠正。
3、如果因为网速或其他原因下载失败请重新下载,重复下载[60天内]不扣币。
4、开具发票登录电脑端申请,请点击【索取发票】。
咨信网客服组:【微信客服】


中国细菌耐药性现状(英文版).ppt
















自信AI助手














微信客服
客服QQ
发送邮件
意见反馈



链接地址:https://www.zixin.com.cn/doc/14673193.html